Plasma levels of tissue factor pathway inhibitor (TFPI)-activated factor Xa (FXa) complex were measured in patients with disseminated intravascular coagulation (DIC), pre-DIC, and DIC. Plasma levels of plasmin-plasmin inhibitor complex (PPIC), D-dimer, and soluble fibrin monomer (SFM) were significa
Venous thrombosis associated with gene deletion of tissue factor pathway inhibitor
β Scribed by Alex Kentsis; Gary Bradwin; David T. Miller; Cameron C. Trenor III
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 250 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To evaluate that the relationship between the truncated form of tissue factor pathway inhibitor (TFPI) and the stage of disseminated intravascular coagulation (DIC), we measured the plasma levels of tissue factor (TF) antigen and the intact and truncated forms of TFPI antigens in 41 patients with DI
Factor V G1691A (FV-Leiden) and prothrombin (PRT) G20210A single nucleotide polymorphisms (SNPs) were associated with venous thrombosis among Caucasians. We assessed the contribution of both SNPs to the genetic susceptibility of deep venous thrombosis (DVT) among Lebanese and Tunisian patients. Subj
TABLE I. Colony-Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 Β± 4.6 Control 2 48.5 Β± 14.1 Before chemotherapy 24.4 Β± 6.2 b After chemotherapy 50.5 Β± 6.5 Values are means Β± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a pa